Press Releases
May 9, 2006 - Cougar Biotechnology Announces Presentation at Rodman & Renshaw 3rd Annual Global Healthcare Conference
Read >> Download | PDF
April 10, 2006 - Cougar Biotechnology Completes Merger and Closes $47.5 Million Private Placement
Read >> Download | PDF
March 23, 2006 - Cougar Biotechnology to Present at SoCalBio Investor Conference
Read >> Download | PDF
December 14, 2005 - Cougar Biotechnology Announces Initiation of Phase I/II trial for CB7630 (Abiraterone Acetate)
Read >> Download | PDF
December 13, 2005 - Cougar Biotechnology Announces Presentation of Positive Preclinical Data for CB3304 (Noscapine) in Non-Hodgkin's Lymphoma and Multiple Myeloma
Read >> Download | PDF
December 12, 2005 - Cougar Biotechnology Announces Positive Interim Results from Phase I trial for CB3304 (Noscapine) in non-Hodgkin's Lymphoma
Read >> Download | PDF
November 2, 2005 - Cougar Biotechnology Announces Presentation at Rodman & Renshaw Techvest 7th Annual Healthcare Conference
Read >> Download | PDF
October 5, 2005 - Cougar Biotechnology Announces Acceptance of CTA for Abiraterone Acetate Read >> Download | PDF
June 28, 2005 - Cougar Biotechnology Licenses Rights to Seocalcitol from LEO Pharma Read >> Download | PDF
February 21, 2005 - Cougar Biotechnology Presents CB7630 Phase I Clinical Data at the 2005 Prostate Cancer Symposium Read >> Download | PDF
November 9, 2004 - Cougar Biotechnology Appoints Vice President of Clinical Research and Development Read >> Download | PDF
October 25, 2004 - Cougar Biotechnology Presents CB7630 Phase I Data at Prostate Cancer Foundation Scientific Retreat Read >> Download | PDF
September 9, 2004 - Cougar Biotechnology Appoints Vice President of Finance Read >> Download | PDF
June 15, 2004 - Cougar Biotechnology Licenses Rights to Emory University?s Noscapine Patent Portfolio Read >> Download | PDF
April 20, 2004 - BTG Licenses New Prostate Cancer Drug to Cougar Biotechnology Read >> Download | PDF
|
|
